Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KIF20B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
YTHDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SARAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM8A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIN7C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP13A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM128 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STXBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PERP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3YL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS13C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM122B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPUL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on